BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7919825)

  • 21. Co-immunization of cattle with a vaccine against babesiosis and Lactobacillus casei increases specific IgG1 levels to Babesia bovis and B. bigemina.
    Bautista-Garfias CR; Lozano AR; Martínez CR; Martínez JA; Millán JV; García GR; Castañeda-Arriola R; Aguilar-Figueroa BR
    Parasitol Int; 2015 Oct; 64(5):319-23. PubMed ID: 25936971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations of breakdowns in protection provided by living Babesia bovis vaccine.
    Bock RE; de Vos AJ; Kingston TG; Shiels IA; Dalgliesh RJ
    Vet Parasitol; 1992 Jun; 43(1-2):45-56. PubMed ID: 1496802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune control of Babesia bovis infection.
    Brown WC; Norimine J; Knowles DP; Goff WL
    Vet Parasitol; 2006 May; 138(1-2):75-87. PubMed ID: 16510249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on failure of T strain live Babesia bovis vaccine.
    Bock RE; de Vos AJ; Lew A; Kingston TG; Fraser IR
    Aust Vet J; 1995 Aug; 72(8):296-300. PubMed ID: 8579560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
    Montenegro-James S; Toro M; Leon E; Guillen AT
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bovine babesiosis live vaccine production: use of gamma irradiation on the substrate.
    Rojas C; Figueroa JV; Alvarado A; Mejia P; Mosqueda JJ; Falcon A; Vega CA; Alvarez A
    Ann N Y Acad Sci; 2006 Oct; 1081():405-16. PubMed ID: 17135544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic Babesia bovis lacking 6-Cys sexual-stage genes as the foundation for non-transmissible live vaccines against bovine babesiosis.
    Alzan HF; Cooke BM; Suarez CE
    Ticks Tick Borne Dis; 2019 Apr; 10(3):722-728. PubMed ID: 30711475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bovine babesiosis: Cattle protected in the field with a frozen vaccine containing Babesia bovis and Babesia bigemina cultured in vitro with a serum-free medium.
    Rojas-Martínez C; Rodríguez-Vivas RI; Millán JVF; Bautista-Garfias CR; Castañeda-Arriola RO; Lira-Amaya JJ; Urióstegui PV; Carrasco JJO; Martínez JAÁ
    Parasitol Int; 2018 Apr; 67(2):190-195. PubMed ID: 29155165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PCR-based detection of the transovarial transmission of Uruguayan Babesia bovis and Babesia bigemina vaccine strains.
    Gayo V; Romito M; Nel LH; Solari MA; Viljoen GJ
    Onderstepoort J Vet Res; 2003 Sep; 70(3):197-204. PubMed ID: 14621315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and pathogenicity of three South African strains of Babesia bovis in Bos indicus cattle.
    De Vos AJ
    Onderstepoort J Vet Res; 1978 Jun; 45(2):119-24. PubMed ID: 714391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of an attenuated live vaccine against babesiosis in native cattle in an endemic area.
    Ojeda JJ; Orozco L; Flores R; Rojas C; Figueroa JV; Alvarez JA
    Transbound Emerg Dis; 2010 Apr; 57(1-2):84-6. PubMed ID: 20537115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cattle responses to mono-specific or combined inoculations with Babesia bigemina and Babesia bovis vaccine strains.
    Viseras J; Lugaresi CI; Volpogni MM; Guglielmone AA
    Parasite; 1999 Mar; 6(1):67-9. PubMed ID: 10229940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Babesia bigemina vaccine: comparison of the efficacy and safety of Australian and South African strains under experimental conditions in South Africa.
    De Vos AJ; Combrink MP; Bessenger R
    Onderstepoort J Vet Res; 1982 Sep; 49(3):155-8. PubMed ID: 7177595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell culture-derived Babesia bovis vaccine: sequential challenge exposure of protective immunity during a 6-month postvaccination period.
    Kuttler KL; Levy MG; Ristic M
    Am J Vet Res; 1983 Aug; 44(8):1456-9. PubMed ID: 6354014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field observations on the duration of immunity in cattle after vaccination against Anaplasma and Babesia species.
    Tjornehoj K; Lawrence JA; Whiteland AP; Kafuwa PT
    Onderstepoort J Vet Res; 1996 Mar; 63(1):1-5. PubMed ID: 8848296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of Bos taurus steers with Babesia bovis recombinant antigens MSA-1, MSA-2c and 12D3.
    Antonio Alvarez J; Lopez U; Rojas C; Borgonio VM; Sanchez V; Castañeda R; Vargas P; Figueroa JV
    Transbound Emerg Dis; 2010 Apr; 57(1-2):87-90. PubMed ID: 20537116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of South African Babesia bovis vaccine against field isolates.
    Troskie PC; Latif AA; Mans BJ; Combrink MP
    Ticks Tick Borne Dis; 2017 Jun; 8(4):671-674. PubMed ID: 28499721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of long-acting oxytetracycline in the immunisation of cattle against Babesia bovis and B bigemina.
    Pipano E; Markovics A; Kriegel Y; Frank M; Fish L
    Res Vet Sci; 1987 Jul; 43(1):64-6. PubMed ID: 3628985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination against bovine babesiosis.
    De Vos AJ; Bock RE
    Ann N Y Acad Sci; 2000; 916():540-5. PubMed ID: 11193669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.